Unravelling the mysteries of the human genome with functional genomics

What is functional genomics technology and how can we use it to improve our chances of finding the right targets for potential medicines?

Why collaboration is essential to achieving new breakthroughs in vaccines

Ahead of the BIO Convention in Philadelphia, Emmanuel Hanon, Senior Vice President, Head of R&D at GSK Vaccines, provides his unique insights on how just one idea combined with the right type of collaboration could change the future of vaccine development.

From eucalyptus toothpaste to a brew for the flu: tailoring products to different tastes

Find out where these ideas for different tastes come from and how they make it onto the shelf.

STEM – inspiring tomorrow’s science and engineering superstars

Meet this year’s GSK UK Young Scientist and Engineers of the Year.

We need more women in science to create the inclusive technologies of the future

To mark International Day of Women and Girls in Science, Nidhi Aggarwal, Global Packaging Development Manager in our Consumer Healthcare business, tells how she reached her current role and explains why we need more diversity of thought in science and applied fields.

Severe asthma: when nature’s natural defences work against us

Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction.

COPD is more than a lung disease

Ruth Tal-Singer works in respiratory research and development. Here she shares her unique perspective on how the future of COPD treatment is changing.

Using the immune system to fight cancer

A paper authored by 44 of our scientists was published in the scientific journal Nature, revealing a potential new class of immunotherapy drugs to treat some cancers.

From bench to bedside: lessons in converting science into impact

Pauline Williams, Head of Global Health R&D, shares a unique perspective on what it takes to research new treatments and deliver them to patients around the world.

TB: uniting scientists to tackle one of the world’s biggest killers

Tuberculosis – better known as TB – is one of the top ten causes of deaths worldwide. But for the first time in almost 100 years, we have taken a major step towards finding a potential new vaccine against the disease.

Inside the Open Lab

How does the Tres Cantos Open Lab offer top international scientists and academics the opportunity to pursue their own projects as part of an integrated team?

The vaccines of tomorrow

Join our leading scientists as they go behind the science of vaccine technology.

You, me and 23andMe: discovering new medicines through genetics

Explore how our new collaboration with 23andMe could help unlock the medicines of tomorrow.

How do consumer insights fuel our innovation?

By asking our consumers what matters to them, we can keep innovating and evolving our products.

How genomics is driving a new era of drug discovery

We’re in a new era of drug discovery because of a fundamental change in our understanding of human biology.

Lupus: the search for a cure continues

Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.

The digitalisation lab: bringing the digital age to manufacturing

We are developing world-class manufacturing innovation to help us bring medicines and consumer healthcare products to people.

COPD: Our relentless pursuit for better breathing

Every person with COPD is different, with different needs, different challenges and different goals. See how we're innovating to determine the right treatment for the right patient.

Getting on target in autoimmune diseases

Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs.But what happens when these cells malfunction?

How smart is your inhaler?

As we investigate new treatments, the ‘internet of things,’ is allowing us to explore the benefits of interconnectivity and the rich patient data that these technologies can provide.

Scientists or detectives? Seeking new clues in COPD

It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently.

Can an iPhone transform the way we monitor and improve patient health?

We are using digital technologies and channels to improve the efficiency of our research, and to improve patient care.

Inhaler innovation: more than a simple piece of plastic

At first glance, an inhaler may look like a simple piece of plastic. But inside, a complicated process and an internal ‘engine’ operate seamlessly...

From microscope to telescope and beyond – exploring with NASA's CASIS

What do space exploration and medical research have in common? And can they help each other?

Turning the tide on antibiotic resistance

Picture a world where people routinely die from minor infections. With an alarming rise in antibiotic resistance in recent years, this almost unthinkable scenario could be a reality.

Vaccine manufacture: it’s complicated

Vaccine manufacture can take anywhere between 6 and 26 months. That’s not to mention the time required to research and develop a new vaccine, which can take up to 30 years.

Playing the innovation game

Besides good timing and even better luck, it’s hard to pinpoint what it takes to be an innovator. Innovators tend to be creative, exceptionally persistent, and prepared to take calculated risks.

Take a deep breath – your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity.

TB or not TB

As recently as 30 years ago, tuberculosis (TB) was believed to be under control.

Bioelectronics at SXSW 2016

SXSW Interactive is a cutting edge technology and digital festival that brings together the brightest minds in emerging technology.

Harnessing the electrical language of the body to treat disease

Bioelectronic medicine is a vision far from today’s medical practice. But we believe that one day, tiny devices, smaller than grains of rice, could be used to restore health in a range of chronic diseases centred on organs and biological functions.

Igniting a revolution in scientific research and development

How can partnerships between science, business and charities help tackle some of the world's most challenging healthcare issues?

Turbocharging the effect of vaccines

When extracted and purified, a compound from the soap bark tree can be mixed with other ingredients to create an ‘adjuvant’, turbocharging the body's immune defences.

Experimental medicine

Studies often employ state-of-the art technology to help scientists and doctors track the effect of a potential new medicine in patients’ bodies.

Outgrowing asthma

Why is it that some people, particularly children, grow out of their asthma? That’s a question our scientists are asking as part of our research to better understand the disease.

Targeting the immune system through open innovation

A functioning immune system is crucial to our health - but what is its role beyond such things as keeping colds at bay and fighting infections?

Keeping ahead of the game

To be the best at what we do, we rely on innovative science to create products capable of transforming the lives of patients.

Fluorescent bacteria - nowhere to hide

How can a new approach known as “bacteria-instructed synthesis” help to tackle bacterial infection?

Cell and gene therapy: a new era of medicine

If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?

The race to richer data in clinical trials

Finding new ways to use biosensors and mobile health platforms to improve patient care.

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Neuroscience: on the brain

The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization.